Focus

Aduhelm

Dementia & Alzheimer's
Dementia & Alzheimer's

Controversial Alzheimer’s Drug Aduhelm Dropped by Drugmaker After Doubtful Data and Denied Coverage

Controversial Alzheimer’s Drug Aduhelm Dropped by Drugmaker After Doubtful Data and Denied Coverage
|
Dementia & Alzheimer's
Dementia & Alzheimer's

Many Ineligible for New Alzheimer’s Drugs: Study

Many Ineligible for New Alzheimer’s Drugs: Study
|
US News
US News

FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe

FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe
|
Policies & Impacts
Policies & Impacts

Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug

Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug
|
Medicine
Medicine

Health: What Patients Need to Know About the Controversial Alzheimer's Drug Aducanumab

FDA Finally Approved an Alzheimer’s Drug—But Everything Surrounding It Is Controversial
|
Health Care
Health Care

Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn

Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn
|
Companies
Companies

Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm

Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm
|
Health News
Health News

Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials

Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials
|
Executive Branch
Executive Branch

Biden Administration Decides to Limit Medicare Coverage of New Alzheimer’s Drug

Biden Administration Decides to Limit Medicare Coverage of New Alzheimer’s Drug
|
Executive Branch
Executive Branch

CMS May Review Medicare Premium in Light of Aduhelm Price Drop

CMS May Review Medicare Premium in Light of Aduhelm Price Drop
|
Health
Health

Biogen Halves Price of Alzheimer’s Drug to $28,200

Biogen Halves Price of Alzheimer’s Drug to $28,200
|
Dementia & Alzheimer's
Dementia & Alzheimer's

Controversial Alzheimer’s Drug Aduhelm Dropped by Drugmaker After Doubtful Data and Denied Coverage

Controversial Alzheimer’s Drug Aduhelm Dropped by Drugmaker After Doubtful Data and Denied Coverage
|
Dementia & Alzheimer's
Dementia & Alzheimer's

Many Ineligible for New Alzheimer’s Drugs: Study

Many Ineligible for New Alzheimer’s Drugs: Study
|
US News
US News

FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe

FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe
|
Policies & Impacts
Policies & Impacts

Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug

Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer’s Drug
|
Medicine
Medicine

Health: What Patients Need to Know About the Controversial Alzheimer's Drug Aducanumab

FDA Finally Approved an Alzheimer’s Drug—But Everything Surrounding It Is Controversial
|
Health Care
Health Care

Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn

Fixed Packaging of Alzheimer’s Drug May Waste $605 Million a Year for Medicare, Experts Warn
|
Companies
Companies

Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm

Biogen CEO to Step Down, Drugmaker Pulls Back on Alzheimer’s Drug Aduhelm
|
Health News
Health News

Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials

Medicare Officially Limits Coverage of Alzheimer’s Drug to Those in Clinical Trials
|
Executive Branch
Executive Branch

Biden Administration Decides to Limit Medicare Coverage of New Alzheimer’s Drug

Biden Administration Decides to Limit Medicare Coverage of New Alzheimer’s Drug
|
Executive Branch
Executive Branch

CMS May Review Medicare Premium in Light of Aduhelm Price Drop

CMS May Review Medicare Premium in Light of Aduhelm Price Drop
|
Health
Health

Biogen Halves Price of Alzheimer’s Drug to $28,200

Biogen Halves Price of Alzheimer’s Drug to $28,200
|